MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8231-8240 Newer>
The Motley Fool
January 12, 2012
Brian Orelli
What to Look For From Pfizer in 2012 Leaner? Yes. Meaner? We'll see. mark for My Articles 663 similar articles
Chemistry World
January 11, 2012
Andrew Turley
BMS spends $2.5 billion on antiviral firm The move will stock Bristol-Myers Squibb's pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating hepatitis C virus infection. mark for My Articles 148 similar articles
IndustryWeek
January 11, 2012
Northeast Indiana's Instrumental Assets Medical-device manufacturers are finding the 10-county Northeast Indiana region a prime location with a skilled workforce. mark for My Articles 11 similar articles
IndustryWeek
January 11, 2012
Life Technologies: IW Best Plants Profile 2011 This plant transformation created a true manufacturing environment in a science-based culture and major revenue wins. mark for My Articles 382 similar articles
The Motley Fool
January 11, 2012
Brian Orelli
A Year's Worth of Sales in 1 Month Regeneron's Eylea hits the gates running. mark for My Articles 48 similar articles
The Motley Fool
January 11, 2012
Dan Caplinger
Has Arena Pharmaceuticals Become the Perfect Stock? Since we looked at Arena Pharmaceuticals last year revenue has fallen back and debt-to-equity levels have soared. mark for My Articles 398 similar articles
The Motley Fool
January 10, 2012
Sean Williams
Could This Stock Nearly Double 2 Years In a Row? Up 96% in 2011, there's a decent chance at a Jazz Pharmaceuticals repeat in 2012. mark for My Articles 33 similar articles
The Motley Fool
January 10, 2012
Sean Williams
2012 Preview: Merck The biggest question mark facing the pharmaceutical behemoth in 2012 is just how badly it will be affected by losing patent-exclusivity rights on its biggest drug, Singulair. mark for My Articles 521 similar articles
The Motley Fool
January 10, 2012
Matt Koppenheffer
Health Management Shares Got Crushed: What You Need to Know Shares of hospital operator Health Management Associates were looking seriously ill today, as they fell as much as 31% after the company's general counsel abruptly resigned. mark for My Articles 6 similar articles
The Motley Fool
January 10, 2012
Sean Williams
Idenix Pharmaceuticals Shares Skyrocketed Again: What You Need to Know Shares of hepatitis-C drug hopeful Idenix Pharmaceuticals are continuing their rally for a second day, currently up 21%, as speculation swirls that it will be the next takeover candidate. mark for My Articles 68 similar articles
<Older 8231-8240 Newer>    Return to current articles.